Study at a glance
How does the liver start converting vitamin D?
This page brings together studies of CYP2R1, an enzyme that helps change vitamin D into 25-hydroxyvitamin D. This is the form measured in most vitamin D blood tests. Making the main active vitamin D hormone requires a separate, later step. The studies ask whether the first conversion can change with conditions in the body.
What did studies of the vitamin D conversion enzyme find?
Rare inherited changes in CYP2R1 were linked to rickets and reduced conversion. A report of 27 people from nine affected families supports its importance, but cannot show how common these problems are. Removing the gene in mice greatly reduced conversion without stopping it completely. High-fat feeding also reduced conversion in liver samples from female mice. These findings do not directly show what happens in human obesity.
Did the human and mouse findings show the same changes?
One human study sampled fat from four women before and after weight-loss surgery. It did not measure recovery of liver conversion. A human-cell model showed less conversion after fatty-acid exposure, but a separate patient liver analysis did not show reduced CYP2R1 production. In another experiment, diabetic mice had lower activity of the CYP2R1 gene but greater overall vitamin D conversion. Gene activity, enzyme amounts and conversion are different measurements.
Can a low vitamin D result identify a liver conversion problem?
CYP2R1 matters, and experimental studies show that conversion can respond to conditions in the body. These studies give less direct evidence about the human liver in ordinary obesity. A low vitamin D blood result alone cannot identify a conversion problem or separate it from low supply and other causes. The evidence does not provide a personal diagnosis, treatment or supplement dose.
Read the full article below ↓CYP2R1 is an enzyme involved in making 25-hydroxyvitamin D, or 25(OH)D, the metabolite measured in most vitamin D blood tests. The evidence shows that conversion can be regulated, while also showing why a low blood result cannot identify one faulty step. For the detailed evidence and methods, see Hepatic CYP2R1 and Vitamin D Conversion: Full Study.
What question does this evidence answer?
The question is whether vitamin D conversion is simply an automatic response to supply, or whether the conversion machinery itself can change. This belongs within Vitamin D and Liver Function. It is different from asking whether supplementation improves a disease or what dose a person needs.
The first conversion produces 25(OH)D. A later, separate conversion produces calcitriol, the principal active hormone. The distinction is explained in Vitamin D Activation. A study must identify which step and which molecule it measured before its findings can be interpreted.
What did the studies find?
Human genetic research by Cheng and colleagues connected a rare CYP2R1 mutation with rickets and impaired vitamin D3 conversion in laboratory cells. It establishes biological importance, not the frequency of that mechanism in ordinary low vitamin D results.
Bakhamis and colleagues subsequently described 27 affected members of nine families. This extends the clinical evidence, while its deliberately selected family cohort cannot estimate the prevalence of conversion defects in the general population.
Mouse deletion experiments by Zhu and colleagues found that removing Cyp2r1 substantially reduced, but did not abolish, 25(OH)D production. In separate dietary experiments, Roizen and colleagues found lower conversion activity in liver preparations from high-fat-fed female mice. Neither experiment directly measures conversion in human obesity.
Elkhwanky’s 2020 study also found lower CYP2R1 protein in the liver of high-fat-fed mice. Its human component sampled fat from four women before and after gastric bypass. The observed expression change therefore cannot be described as recovery of the human liver.
Hammour’s 2026 human-cell model found reduced conversion after fatty-acid exposure. However, its separate patient liver analysis did not show reduced CYP2R1 expression. Laboratory findings and patient tissue findings therefore remain distinct.
Aatsinki’s experiments linked metabolic regulation to CYP2R1 expression. However, a later diabetic-mouse study by Elkhwanky found lower Cyp2r1 expression alongside increased conversion activity. A fall in one expression measurement therefore does not guarantee a fall in overall production.
Why do these distinctions matter?
The studies ask related questions with different tools. A mutation can alter the protein’s function; a dietary experiment can change several physiological conditions simultaneously; a tissue biopsy measures that tissue; and a blood sample measures what is circulating. Combining them is useful only if those boundaries remain visible.
The key interpretive task is to keep expression, enzyme activity and circulating concentration separate. A coherent explanation becomes stronger when independent measurements agree. A result that disagrees with the proposed explanation must also be retained. The broader relationship between local conversion and biological response is explained in Vitamin D Metabolism at the Cellular Level.
What can reasonably be concluded?
CYP2R1 is an important part of vitamin D conversion, and the experimental evidence shows that this step can respond to metabolic conditions. The human liver consequences of ordinary obesity are less directly established by these particular studies than the mouse findings.
A vitamin D blood result alone cannot reveal how much of its value comes from supply, conversion or other processes. This evidence does not provide a test for personal conversion failure, a treatment recommendation or a reason to transfer experimental animal doses into human use.
Scientific sources
Cheng JB et al. Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proceedings of the National Academy of Sciences. 2004;101(20):7711 to 7715. DOI: 10.1073/pnas.0402490101.
Bakhamis S et al. 25-Hydroxylase vitamin D deficiency in 27 Saudi Arabian subjects: a clinical and molecular report on CYP2R1 mutations. Endocrine Connections. 2021;10(7):767 to 775. DOI: 10.1530/EC-21-0102.
Zhu JG et al. CYP2R1 is a major, but not exclusive, contributor to 25-hydroxyvitamin D production in vivo. Proceedings of the National Academy of Sciences. 2013;110(39):15650 to 15655. DOI: 10.1073/pnas.1315006110.
Roizen JD et al. Obesity Decreases Hepatic 25-Hydroxylase Activity Causing Low Serum 25-Hydroxyvitamin D. Journal of Bone and Mineral Research. 2019;34(6):1068 to 1073. DOI: 10.1002/jbmr.3686.
Elkhwanky MS et al. Obesity Represses CYP2R1, the Vitamin D 25-Hydroxylase, in the Liver and Extrahepatic Tissues. JBMR Plus. 2020;4(11):e10397. DOI: 10.1002/jbm4.10397.
Hammour MM et al. Free Fatty acid-induced disruption of hepatic vitamin D metabolism impairs bone homeostasis in an in vitro 3D human liver: bone model. Archives of Toxicology. 2026;100:4151 to 4169. DOI: 10.1007/s00204-026-04431-x.
Aatsinki SM et al. Fasting-Induced Transcription Factors Repress Vitamin D Bioactivation, a Mechanism for Vitamin D Deficiency in Diabetes. Diabetes. 2019;68(5):918 to 931. DOI: 10.2337/db18-1050.
Elkhwanky MS, Kummu O, Hakkola J. Streptozotocin-induced Diabetes Represses Hepatic CYP2R1 Expression but Induces Vitamin D 25-Hydroxylation in Male Mice. Endocrinology. 2022;163(7):bqac060. DOI: 10.1210/endocr/bqac060.
Related reading
Obesity Represses CYP2R1, the Vitamin D 25‐Hydroxylase, in the Liver and Extrahepatic Tissues
Low plasma level of 25‐hydroxyvitamin D (25‐OH‐D), namely vitamin D deficiency, is associated with obesity and weight loss improves 25‐OH‐D status.
Original paper ↗Read more →Therapeutic plasma exchange in hypertriglyceridemic patients
In this study, the results of TPE were evaluated and the frequency of lipoprotein lipase (LPL) mutation in these patients was determined.
Original paper ↗Read more →Streptozotocin-induced Diabetes Represses Hepatic CYP2R1 Expression but Induces Vitamin D 25-Hydroxylation in Male Mice
Vitamin D deficiency [ie, low plasma 25-hydroxyvitamin D (25-OH-D)] associates with the prevalence of metabolic diseases including type 1 diabetes; however, the molecular mechanisms are incompletely understood.
Original paper ↗Read more →Hepatic CYP2R1 and Vitamin D Conversion: Full Study
How CYP2R1 converts vitamin D: human genetic evidence, mouse liver experiments, metabolic regulation and the limits of interpreting blood 25(OH)D.
Read more →Dietary Vitamin D Insufficiency Aggravates High-Fat Diet-Induced Hepatic Steatosis Associated with Reduced Hepatic SIRT1 Activity and Nrf2-Related Antioxidant Gene Expression in Male C57BL/6J Mice
As obesity continues to increase globally, it has become a major contributor to the growing burden of metabolic diseases, including type 2 diabetes mellitus, cardiovascular disease, and nonalcoholic fatty liver disease (NAFLD).
Original paper ↗Read more →Protective Effect of Vitamin D against Hepatic Molecular Apoptosis Caused by a High-Fat Diet in Rats
We aimed in this study to investigate the protective effects of VitD on hepatic molecular apoptotic changes in response to an HFD in rats.
Original paper ↗Read more →Ultraviolet exposure of mice fed a high fat diet reduces weight gain and markers of liver disease progression
Research suggests that ultraviolet (UV) exposure of mice placed on a high fat diet can reduce incidence of metabolic disease.
Original paper ↗Read more →A high-fat diet stimulates fibroblast growth factor 23 formation in mice through TNFα upregulation
We investigated the relevance of TNFα for high-fat diet (HFD)-induced FGF23 formation in wild-type (tnf+/+) and TNFα-deficient (tnf−/−) mice.
Original paper ↗Read more →Disrupted Vitamin D Metabolism in Hepatocellular Carcinoma: Free and Bioavailable 25(OH)D as Novel Biomarkers of Hepatic Reserve and Clinical Risk
Correlations with Child: Pugh score, Barcelona Clinic Liver Cancer (BCLC) stage, and disease aetiology were evaluated.
Original paper ↗Read more →Effects of high fat diet-induced obesity on vitamin D metabolism and tissue distribution in vitamin D deficient or supplemented mice
However, only few studies have investigated this mechanism via quantifying vitamin D levels from tissues from the obese.
Original paper ↗Read more →Glutathione deficiency induces epigenetic alterations of vitamin D metabolism genes in the livers of high-fat diet-fed obese mice
This study investigated whether GSH deficiency induces epigenetic alterations that impair Vitamin D (VD) metabolism genes in the livers of HFD-fed mice.
Original paper ↗Read more →Association of longitudinal serum 25-hydroxyvitamin D trajectories with subsequent liver stiffness increase in patients with early-onset type 2 diabetes and metabolic dysfunction-associated steatotic liver disease
We evaluated the associations of longitudinal 25(OH)D trajectories with subsequent liver stiffness measurement (LSM) increases in patients with early-onset type 2 diabetes and metabolic dysfunction-associated steatotic liver disease.
Original paper ↗Read more →Correlation of Vitamin 25(OH)D, Liver Enzymes, Potassium, and Oxidative Stress Markers with Lipid Profile and Atheromatic Index: A Pilot Study
This study aims to investigate the correlation of lipid profile and atheromatic index TC/HDL with several biomarkers and oxidative stress parameters.
Original paper ↗Read more →Correlational study on the levels of 25-hydroxyvitamin D and non-alcoholic fatty liver disease in type 2 diabetic patients
The objective of this study is to retrospectively probe the association between the 25-hydroxyvitamin D (25-(OH)D) and NAFLD in type 2 diabetic patients.
Original paper ↗Read more →Higher Serum 25-Hydroxyvitamin D Is Associated with Lower All-Cause and Cardiovascular Mortality among US Adults with Nonalcoholic Fatty Liver Disease
Aims: We aimed to assess the association between serum 25-hydroxyvitamin D (25(OH)D) levels with all-cause and cardiovascular mortality in patients with nonalcoholic fatty liver disease (NAFLD).
Original paper ↗Read more →Liver Graft Pathology and Low Serum 25-Hydroxyvitamin D after Living Donor Liver Transplantation
Aims: We conducted this study to explore the interplay between VDR and CYP2R1 in liver graft and compared our findings with the pathological interpretation of serum 25(OH)D concentration.
Original paper ↗Read more →Low Serum 25-Hydroxyvitamin D Levels Are Related to Frailty and Sarcopenia in Patients with Chronic Liver Disease
This study aimed at exploring the relationship between serum 25-hydroxyvitamin D [25(OH)D] levels and frailty or sarcopenia in 231 patients with CLD.
Original paper ↗Read more →Seasonal Variation in 25(OH)D at Aberdeen (57°N) and Bone Health Indicators: Could Holidays in the Sun and Cod Liver Oil Supplements Alleviate Deficiency?
The aim of this longitudinal study, was to assess predictors of seasonal variation of 25-hydroxy-vitamin D (25(OH)D) (including use of supplements and holidays in sunny destinations) at a northerly latitude in the UK (57°N) in relation to bone health indicators.
Original paper ↗Read more →Vitamin D and Liver Function
Explore how vitamin D and liver function interact through metabolism, insulin signalling, immune balance, and tissue regulation in a physiology-first framework.
Read more →Low 25-Hydroxyvitamin D Levels Are Associated with Infections and Mortality in Patients with Cirrhosis
We here investigated if low vitamin D levels might be associated with prognosis, inflammation and infectious complications in patients with cirrhosis.
Original paper ↗Read more →Serum 25-hydroxyvitamin D levels are associated with carotid atherosclerosis in normotensive and euglycemic Chinese postmenopausal women: the Shanghai Changfeng study
We investigated whether the 25 (OH) D is independently associated with the carotid intima: media thickness (CIMT) and carotid plaques in normotensive and euglycemic postmenopausal women.
Original paper ↗Read more →Original sources
Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase
Published in Proceedings of the National Academy of Sciences (2004).
Publication details
Cheng JB et al. Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proceedings of the National Academy of Sciences. 2004;101(20):7711 to 7715. DOI: 10.1073/pnas.0402490101.
25-Hydroxylase vitamin D deficiency in 27 Saudi Arabian subjects: a clinical and molecular report on CYP2R1 mutations
Published in Endocrine Connections (2021).
Publication details
Bakhamis S et al. 25-Hydroxylase vitamin D deficiency in 27 Saudi Arabian subjects: a clinical and molecular report on CYP2R1 mutations. Endocrine Connections. 2021;10(7):767 to 775. DOI: 10.1530/EC-21-0102.
CYP2R1 is a major, but not exclusive, contributor to 25-hydroxyvitamin D production in vivo
Published in Proceedings of the National Academy of Sciences (2013).
Publication details
Zhu JG et al. CYP2R1 is a major, but not exclusive, contributor to 25-hydroxyvitamin D production in vivo. Proceedings of the National Academy of Sciences. 2013;110(39):15650 to 15655. DOI: 10.1073/pnas.1315006110.
Obesity Decreases Hepatic 25-Hydroxylase Activity Causing Low Serum 25-Hydroxyvitamin D
Published in Journal of Bone and Mineral Research (2019).
Publication details
Roizen JD et al. Obesity Decreases Hepatic 25-Hydroxylase Activity Causing Low Serum 25-Hydroxyvitamin D. Journal of Bone and Mineral Research. 2019;34(6):1068 to 1073. DOI: 10.1002/jbmr.3686.
Obesity Represses CYP2R1, the Vitamin D 25‐Hydroxylase, in the Liver and Extrahepatic Tissues
Low plasma level of 25‐hydroxyvitamin D (25‐OH‐D), namely vitamin D deficiency, is associated with obesity and weight loss improves 25‐OH‐D status.
Publication details
Elkhwanky MS et al. Obesity Represses CYP2R1, the Vitamin D 25-Hydroxylase, in the Liver and Extrahepatic Tissues. JBMR Plus. 2020;4(11):e10397. DOI: 10.1002/jbm4.10397.
Free Fatty acid-induced disruption of hepatic vitamin D metabolism impairs bone homeostasis in an in vitro 3D human liver–bone model
Published in Archives of Toxicology (2026).
Publication details
Hammour MM et al. Free Fatty acid-induced disruption of hepatic vitamin D metabolism impairs bone homeostasis in an in vitro 3D human liver: bone model. Archives of Toxicology. 2026;100:4151 to 4169. DOI: 10.1007/s00204-026-04431-x.
Fasting-Induced Transcription Factors Repress Vitamin D Bioactivation, a Mechanism for Vitamin D Deficiency in Diabetes
Published in Diabetes (2019).
Publication details
Aatsinki SM et al. Fasting-Induced Transcription Factors Repress Vitamin D Bioactivation, a Mechanism for Vitamin D Deficiency in Diabetes. Diabetes. 2019;68(5):918 to 931. DOI: 10.2337/db18-1050.
Streptozotocin-induced Diabetes Represses Hepatic CYP2R1 Expression but Induces Vitamin D 25-Hydroxylation in Male Mice
Vitamin D deficiency [ie, low plasma 25-hydroxyvitamin D (25-OH-D)] associates with the prevalence of metabolic diseases including type 1 diabetes; however, the molecular mechanisms are incompletely understood.
Publication details
Elkhwanky MS, Kummu O, Hakkola J. Streptozotocin-induced Diabetes Represses Hepatic CYP2R1 Expression but Induces Vitamin D 25-Hydroxylation in Male Mice. Endocrinology. 2022;163(7):bqac060. DOI: 10.1210/endocr/bqac060.